Not applicableLooking for participantsNCT06548529
What this trial is testing
HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADC
Who this might be right for
HER2 Positive or Suspicious Positive Tumors
Peking University Cancer Hospital & Institute 30